AU2001248994A1 - Use of substances with oxytocin activity against climacteric disorders - Google Patents
Use of substances with oxytocin activity against climacteric disordersInfo
- Publication number
- AU2001248994A1 AU2001248994A1 AU2001248994A AU4899401A AU2001248994A1 AU 2001248994 A1 AU2001248994 A1 AU 2001248994A1 AU 2001248994 A AU2001248994 A AU 2001248994A AU 4899401 A AU4899401 A AU 4899401A AU 2001248994 A1 AU2001248994 A1 AU 2001248994A1
- Authority
- AU
- Australia
- Prior art keywords
- activity against
- substances
- climacteric disorders
- oxytocin activity
- against climacteric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to the use of substances with oxytocin activity against climacteric disorders or similar symptoms due to dysfunction in the ovaries. It also relates to a pharmaceutical composition comprising at least one substance with oxytocin activity against climacteric disorders.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0001440 | 2000-04-18 | ||
SE0001440A SE0001440D0 (en) | 2000-04-18 | 2000-04-18 | A drug against climacteric disorders |
PCT/SE2001/000854 WO2001078758A1 (en) | 2000-04-18 | 2001-04-18 | Use of substances with oxytocin activity against climacteric disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001248994A1 true AU2001248994A1 (en) | 2001-10-30 |
Family
ID=20279369
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001248994A Abandoned AU2001248994A1 (en) | 2000-04-18 | 2001-04-18 | Use of substances with oxytocin activity against climacteric disorders |
Country Status (8)
Country | Link |
---|---|
US (2) | US20040029787A1 (en) |
EP (1) | EP1406649B9 (en) |
AT (1) | ATE387213T1 (en) |
AU (1) | AU2001248994A1 (en) |
DE (1) | DE60133050T2 (en) |
ES (1) | ES2302728T3 (en) |
SE (1) | SE0001440D0 (en) |
WO (1) | WO2001078758A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0100684D0 (en) * | 2001-02-28 | 2001-02-28 | Kerstin Uvnaes Moberg | New subject matter |
JO2937B1 (en) | 2004-08-11 | 2016-03-15 | فيرينغ.بي.في | Peptidic Vasopressin Receptor Agonists |
NZ569836A (en) | 2006-02-10 | 2010-09-30 | Ferring Bv | Novel compounds |
WO2009037586A2 (en) | 2007-08-14 | 2009-03-26 | Ferring B.V. | Use of peptidic vasopressin receptor agonists |
CA2704724A1 (en) * | 2007-09-11 | 2009-04-16 | Mondobiotech Laboratories Ag | 5use of a peptide as a therapeutic agent |
KR20100057046A (en) * | 2007-09-11 | 2010-05-28 | 몬도바이오테크 래보래토리즈 아게 | Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections |
WO2009046865A2 (en) * | 2007-09-11 | 2009-04-16 | Mondobiotech Laboratories Ag | Cholecystokinin-33 alone or in combination with trap-14 as therapeutic agent |
WO2009033820A2 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
WO2009043455A2 (en) * | 2007-09-11 | 2009-04-09 | Mondobiotech Laboratories Ag | Therapeutic uses of angiogenin 108-122 and gluten exorphin a5 |
SE536091C2 (en) | 2011-04-14 | 2013-04-30 | Pep Tonic Medical Ab | Pharmaceutical composition containing oxytocin or fragments or variants thereof and at least one non-ionic cellulose ether |
EP2908840A1 (en) * | 2012-10-12 | 2015-08-26 | Peptonic Medical AB | Novel use of a composition comprising oxytocin |
SE1750680A1 (en) | 2017-05-30 | 2018-12-01 | Peptonic Medical Ab | Composition for treating or preventing climacteric disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4889844A (en) * | 1985-10-22 | 1989-12-26 | Silvetti Sr Anthony N | Fructose containing wound healing preparation |
CA2110176A1 (en) * | 1992-03-28 | 1993-10-14 | Akira Yanagawa | Topical preparation for healing wounds of the skin |
MY117988A (en) * | 1995-10-03 | 2004-08-30 | Nor Ind Inc | Cleaning compositions for oil and gas well, lines, casings, formations and equipment and methods of use |
US5753266A (en) * | 1996-12-03 | 1998-05-19 | Youssefyeh; Parvin | Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases |
SE9701162D0 (en) * | 1997-03-27 | 1997-03-27 | Karolinska Innovations Ab | New use II |
SE9803272D0 (en) * | 1998-09-25 | 1998-09-25 | Kerstin Uvnaes Moberg | A drug for cell regeneration |
US6333313B1 (en) * | 1998-10-29 | 2001-12-25 | Board Of Regents, The University Of Texas System | Clinical use of oxytocin alone or in combination to treat bone disorders |
SE0100684D0 (en) | 2001-02-28 | 2001-02-28 | Kerstin Uvnaes Moberg | New subject matter |
-
2000
- 2000-04-18 SE SE0001440A patent/SE0001440D0/en unknown
-
2001
- 2001-04-18 ES ES01922220T patent/ES2302728T3/en not_active Expired - Lifetime
- 2001-04-18 WO PCT/SE2001/000854 patent/WO2001078758A1/en active IP Right Grant
- 2001-04-18 EP EP01922220A patent/EP1406649B9/en not_active Expired - Lifetime
- 2001-04-18 DE DE60133050T patent/DE60133050T2/en not_active Expired - Lifetime
- 2001-04-18 US US10/258,013 patent/US20040029787A1/en not_active Abandoned
- 2001-04-18 AU AU2001248994A patent/AU2001248994A1/en not_active Abandoned
- 2001-04-18 AT AT01922220T patent/ATE387213T1/en active
-
2006
- 2006-02-02 US US11/345,218 patent/US7727959B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1406649B9 (en) | 2008-10-15 |
DE60133050D1 (en) | 2008-04-10 |
WO2001078758A1 (en) | 2001-10-25 |
SE0001440D0 (en) | 2000-04-18 |
US7727959B2 (en) | 2010-06-01 |
DE60133050T2 (en) | 2009-02-26 |
ES2302728T3 (en) | 2008-08-01 |
ATE387213T1 (en) | 2008-03-15 |
EP1406649A1 (en) | 2004-04-14 |
US20060148685A1 (en) | 2006-07-06 |
EP1406649B1 (en) | 2008-02-27 |
US20040029787A1 (en) | 2004-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002016402A3 (en) | Apoptotic compounds | |
IL218698A0 (en) | Compounds that inhibit serine protease activity and pharmaceutical compositions containing the same | |
IL152315A0 (en) | Soluble ctla4 mutant molecules and pharmaceutical compositions containing the same | |
MXPA03003705A (en) | Self contained liquid atomizer assembly. | |
BRPI0112859B8 (en) | somatostatin analogues, pharmaceutical composition, as well as the use of said analogues | |
EP0960621A3 (en) | Pharmaceutical formulations comprising sildenafil | |
WO2004089396A3 (en) | Anti-fungal peptidomimetics | |
AP2003002916A0 (en) | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis. | |
EP1344780A4 (en) | Glucopyranosyloxybenzyl benzene derivatives, medicinal compositions containing the same and intermediates in the production thereof | |
DK1091975T3 (en) | New cyclosporine with improved activity profile | |
IL152448A0 (en) | 3-nitrogen-6, 7-dioxygen steroid derivatives and pharmaceutical compositions containing the same | |
BG106075A (en) | Use of cyp2d6 inhibitors in combination therapies | |
IL175210A0 (en) | Non-pancreatic proteases and pharmaceutical compositions containing the same | |
BR0009480A (en) | Polyurethane solutions with alkoxysilane structure units | |
AU2001248994A1 (en) | Use of substances with oxytocin activity against climacteric disorders | |
HUP0401638A3 (en) | Thiopene-amides, thiazolesulfonamides as antineoplastic agents, and pharmaceutical composition containing the same | |
WO2006056696A3 (en) | 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof | |
CA2270177A1 (en) | Transdermal administration of ment | |
AU8738401A (en) | Novel kallikrein gene | |
IT1320080B1 (en) | COMPOSITION FOR PHARMACEUTICAL OR DIETARY USE. | |
WO2002015959A3 (en) | Compounds and compositions for delivering active agents | |
IL139318A (en) | Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same | |
BG106316A (en) | Ambroxol-containing lozenge | |
SE9803272D0 (en) | A drug for cell regeneration | |
AU2001278680A1 (en) | Erectile dysfunction remedies containing prostaglandin derivatives as the activeingredient |